These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 6319045)
21. [Comparison of captopril with enalapril in the therapy of heart failure: effect on hemodynamics and kidney function]. Osterziel KJ; Dietz R; Mikulaschek K; Röhrig N; Schmid W; Manthey J; Kübler W Z Kardiol; 1988 Jun; 77(6):378-84. PubMed ID: 2850682 [TBL] [Abstract][Full Text] [Related]
22. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction. Mantle JA; Russell RO; Moraski RE; Rackley CE Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634 [TBL] [Abstract][Full Text] [Related]
23. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Curtiss C; Cohn JN; Vrobel T; Franciosa JA Circulation; 1978 Nov; 58(5):763-70. PubMed ID: 699245 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy. Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders. Packer M; Medina N; Yushak M Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434 [TBL] [Abstract][Full Text] [Related]
26. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure. Petein M; Levine TB; Cohn JN Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778 [TBL] [Abstract][Full Text] [Related]
27. Hemodynamic effects of lisinopril after long-term administration in congestive heart failure. Stone CK; Uretsky BF; Linnemeier TJ; Shah PK; Amin DK; Snapinn SM; Rush JE; Langendörfer A; Liang CS Am J Cardiol; 1989 Mar; 63(9):567-70. PubMed ID: 2537566 [TBL] [Abstract][Full Text] [Related]
28. A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure. Insel J; Mirvis DM; Boland MJ; Cinquegrani MP; Shanes J; Rubin SA; Whalen JJ Clin Pharmacol Ther; 1989 Mar; 45(3):312-20. PubMed ID: 2537699 [TBL] [Abstract][Full Text] [Related]
29. Systemic, pulmonary, brachial, renal and hepato-splanchnic hemodynamic effects of spirapril in severe congestive heart failure. Bellissant E; Annane D; Pussard E; Thuillez C; Giudicelli JF Fundam Clin Pharmacol; 1996; 10(2):127-35. PubMed ID: 8737955 [TBL] [Abstract][Full Text] [Related]
30. A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure. Jamieson MJ; Webster J; Fowler G; Rawles J; Smith FW; Petrie JC Br J Clin Pharmacol; 1991 Mar; 31(3):305-12. PubMed ID: 1675867 [TBL] [Abstract][Full Text] [Related]
31. Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. Franciosa JA; Wilen MM; Jordan RA J Am Coll Cardiol; 1985 Jan; 5(1):101-7. PubMed ID: 2981088 [TBL] [Abstract][Full Text] [Related]
32. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans. Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713 [TBL] [Abstract][Full Text] [Related]
33. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure. Kubo SH; Fox SC; Prida XE; Cody RJ Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315 [TBL] [Abstract][Full Text] [Related]
35. Dose-ranging study of isosorbide-5-mononitrate in chronic congestive heart failure treated with diuretics and angiotensin-converting enzyme inhibitor. Debbas N; Woodings D; Marks C; Bhans A; Jubber A; Dews I; Stephens J; Vandenburg M Am J Cardiol; 1988 Mar; 61(9):28E-30E. PubMed ID: 2831702 [TBL] [Abstract][Full Text] [Related]
36. Immediate converting-enzyme inhibition with intravenous enalapril in chronic congestive heart failure. Kubo SH; Cody RJ; Laragh JH; Prida XE; Atlas SA; Yuan Z; Sealey JE Am J Cardiol; 1985 Jan; 55(1):122-6. PubMed ID: 2981462 [TBL] [Abstract][Full Text] [Related]
37. MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response. Uretsky BF; Generalovich T; Verbalis JG; Valdes AM; Reddy PS J Am Coll Cardiol; 1985 Jun; 5(6):1414-21. PubMed ID: 3158689 [TBL] [Abstract][Full Text] [Related]